JP2019504087A5 - - Google Patents

Download PDF

Info

Publication number
JP2019504087A5
JP2019504087A5 JP2018540115A JP2018540115A JP2019504087A5 JP 2019504087 A5 JP2019504087 A5 JP 2019504087A5 JP 2018540115 A JP2018540115 A JP 2018540115A JP 2018540115 A JP2018540115 A JP 2018540115A JP 2019504087 A5 JP2019504087 A5 JP 2019504087A5
Authority
JP
Japan
Prior art keywords
cancer
syndrome
disease
autoimmune
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018540115A
Other languages
English (en)
Japanese (ja)
Other versions
JP7104627B2 (ja
JP2019504087A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/016516 external-priority patent/WO2017136731A1/en
Publication of JP2019504087A publication Critical patent/JP2019504087A/ja
Publication of JP2019504087A5 publication Critical patent/JP2019504087A5/ja
Application granted granted Critical
Publication of JP7104627B2 publication Critical patent/JP7104627B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018540115A 2016-02-04 2017-02-03 ラパグルチン(rapaglutins)、glutの新規阻害剤及びその使用 Active JP7104627B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662291453P 2016-02-04 2016-02-04
US62/291,453 2016-02-04
PCT/US2017/016516 WO2017136731A1 (en) 2016-02-04 2017-02-03 Rapaglutins, novel inhibitors of glut and use thereof

Publications (3)

Publication Number Publication Date
JP2019504087A JP2019504087A (ja) 2019-02-14
JP2019504087A5 true JP2019504087A5 (cg-RX-API-DMAC10.html) 2020-02-13
JP7104627B2 JP7104627B2 (ja) 2022-07-21

Family

ID=59500972

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018540115A Active JP7104627B2 (ja) 2016-02-04 2017-02-03 ラパグルチン(rapaglutins)、glutの新規阻害剤及びその使用

Country Status (8)

Country Link
US (1) US11708391B2 (cg-RX-API-DMAC10.html)
EP (1) EP3411046B1 (cg-RX-API-DMAC10.html)
JP (1) JP7104627B2 (cg-RX-API-DMAC10.html)
CN (1) CN108697729B (cg-RX-API-DMAC10.html)
AU (1) AU2017213630B2 (cg-RX-API-DMAC10.html)
CA (1) CA3013783A1 (cg-RX-API-DMAC10.html)
MX (1) MX2018009408A (cg-RX-API-DMAC10.html)
WO (1) WO2017136731A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108697729B (zh) 2016-02-04 2023-05-09 约翰霍普金斯大学 新型GLUT抑制剂rapaglutin及其用途
US11066416B2 (en) 2016-02-04 2021-07-20 The Johns Hopkins University Rapafucin derivative compounds and methods of use thereof
AU2017214557B2 (en) * 2016-02-04 2022-05-19 The Johns Hopkins University Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof
WO2021067405A1 (en) * 2019-10-01 2021-04-08 The Johns Hopkins University Neuroprotective compounds and methods of use thereof
TW202126323A (zh) * 2019-10-01 2021-07-16 約翰斯赫普金斯大學 雷帕弗辛(Rapafucin)衍生化合物及其使用方法
CN112294792B (zh) * 2020-09-22 2021-10-22 厦门市中医院 化合物wzb117在制备治疗和/或预防肝损伤药物中的用途
CN115364224B (zh) * 2022-08-25 2024-02-02 杭州天玑济世生物科技有限公司 Glut1抑制剂作为线粒体自噬诱导剂的用途
CN120271673A (zh) * 2024-01-08 2025-07-08 重庆医科大学 一种化合物、包含其的药物组合物及其用途
CN120617307B (zh) * 2025-06-16 2025-12-09 烟台大学 一种wzb117纳米制剂及其制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100899A (en) 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
US5457194A (en) 1993-03-17 1995-10-10 Abbott Laboratories Substituted aliphatic amine-containing macrocyclic immunomodulators
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
US5527907A (en) 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
US5696135A (en) 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US7056935B2 (en) 1995-06-07 2006-06-06 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US6984635B1 (en) 1998-02-13 2006-01-10 Board Of Trustees Of The Leland Stanford Jr. University Dimerizing agents, their production and use
EP1352910A1 (en) 2002-04-10 2003-10-15 Grünenthal GmbH New analogs of nitrobenzylthioinosine
WO2004093798A2 (en) 2003-04-18 2004-11-04 Enanta Pharmaceuticals, Inc. Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
US20060003362A1 (en) 2004-06-04 2006-01-05 Xenoport, Inc. ENT1 transporters expressed in cancer cells
GB0417852D0 (en) 2004-08-11 2004-09-15 Biotica Tech Ltd Production of polyketides and other natural products
JP2009513135A (ja) 2005-10-28 2009-04-02 プリーシス・ファーマシューティカルズ・インコーポレイテッド エンコードされたライブラリーを用いて興味のある化合物を同定する方法
US20080306098A1 (en) 2006-11-06 2008-12-11 Mutz Mitchell W Pharmacokinetics of protease inhibitors and other drugs
EP3417859A1 (en) 2007-03-07 2018-12-26 Abraxis BioScience, LLC Nanoparticle comprising rapamycin and albumin as anticancer agent
JP2010527618A (ja) 2007-05-24 2010-08-19 アメリカ合衆国 ヌクレオシドサルベージ経路を通しての核内タンパク質伝達
WO2010004304A1 (en) 2008-06-17 2010-01-14 Biotica Technology Limited Novel compounds and methods for their production
AU2011336727B2 (en) * 2010-11-30 2016-11-03 The Johns Hopkins University Hybrid cyclic libraries and screens thereof
WO2012106702A2 (en) 2011-02-04 2012-08-09 The General Hospital Corporation Treatment of leukemia
EP2607352A1 (en) 2011-12-22 2013-06-26 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Pipecolate-diketoamides for treatment of psychiatric disorders
KR101733736B1 (ko) 2012-01-06 2017-05-10 삼성에스디아이 주식회사 리튬 이차 전지용 음극 활물질, 그 제조 방법 및 이를 포함하는 리튬 이차 전지
WO2014008636A1 (en) 2012-07-11 2014-01-16 Merck Sharp & Dohme Corp. Macrocyclic compounds as hiv integrase inhibitors
US10167259B2 (en) 2013-06-14 2019-01-01 The Board Of Regents Of The University Of Texas System Allosteric inhibitors of proteasome and methods of use thereof
WO2016112295A1 (en) 2015-01-09 2016-07-14 Warp Drive Bio, Inc. Compounds that participate in cooperative binding and uses thereof
CA3000822A1 (en) 2015-10-01 2017-04-06 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
CN108697729B (zh) 2016-02-04 2023-05-09 约翰霍普金斯大学 新型GLUT抑制剂rapaglutin及其用途
WO2017136708A1 (en) 2016-02-04 2017-08-10 The Johns Hopkins University Synthesis and composition of rapafucin libraries
US11066416B2 (en) 2016-02-04 2021-07-20 The Johns Hopkins University Rapafucin derivative compounds and methods of use thereof
AU2017214557B2 (en) * 2016-02-04 2022-05-19 The Johns Hopkins University Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof
CR20180499A (es) 2016-04-22 2019-01-25 Astrazeneca Ab Inhibidores de mcl1 macrocicliclos para tratar el cancer
US20190224274A1 (en) 2016-09-02 2019-07-25 The Johns Hopkins University Mif inhibitors and methods of use thereof
UY37900A (es) 2017-09-26 2019-04-30 Novartis Ag Nuevos derivados de rapamicina

Similar Documents

Publication Publication Date Title
JP2019509986A5 (cg-RX-API-DMAC10.html)
EP3411121B1 (en) Glucose conjugates of triptolide, analogs and uses thereof
AU2012274160B2 (en) Deuterium-enriched 4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo- N-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
JP2016505019A5 (cg-RX-API-DMAC10.html)
JP2019529444A5 (cg-RX-API-DMAC10.html)
JP2020517616A5 (cg-RX-API-DMAC10.html)
JP2021529780A5 (cg-RX-API-DMAC10.html)
JP2016506916A5 (cg-RX-API-DMAC10.html)
JP2021512166A5 (cg-RX-API-DMAC10.html)
JP2022540333A5 (cg-RX-API-DMAC10.html)
JP2008506683A5 (cg-RX-API-DMAC10.html)
JP2013510860A5 (cg-RX-API-DMAC10.html)
HRP20250969T1 (hr) Triciklički parp1 inhibitori i njihove uporabe
JP3200421B2 (ja) 化学療法剤としての新規ビス白金錯体
JP2016508505A5 (cg-RX-API-DMAC10.html)
JP2007511504A5 (cg-RX-API-DMAC10.html)
JP2011529919A5 (cg-RX-API-DMAC10.html)
JP2021501151A5 (cg-RX-API-DMAC10.html)
JP2014510147A5 (cg-RX-API-DMAC10.html)
JP2017518344A5 (cg-RX-API-DMAC10.html)
Krüger et al. Synthesis and X‐ray Crystal Structures of Ga‐substituted Distibenes [L (X) GaSb] 2
JP2015502979A5 (cg-RX-API-DMAC10.html)
JP2024531259A5 (cg-RX-API-DMAC10.html)
JP2016528242A5 (cg-RX-API-DMAC10.html)
JP2016508135A5 (cg-RX-API-DMAC10.html)